Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1047 | Pituitary and Neuroendocrinology 3 | ECE2019

Cerebrovascular events, secondary intracranial tumors and other neoplasia following radiotherapy for non-acromegaly pituitary tumors and craniopharyngiomas

Trifanescu Raluca , Smarandoiu Alexandra , Pascu Polina , Dumitrascu Anda , Pascu Alina , Trifanescu Oana , Anghel Rodica , Poiana Catalina

Background: Radiotherapy is part of the complex treatment of pituitary tumors; it is an effective treatment for residual postoperative tumors or recurrent tumors, but cerebrovascular events and secondary intracranial tumors may occur during long term follow-up.Aim: To assess prevalence of cerebrovascular events, secondary intracranial tumors and other neoplasia in patients with non-acromegaly pituitary tumors and craniopharyngiomas submitted to radiother...

ea0094p50 | Endocrine Cancer and Late Effects | SFEBES2023

Survival rates in metastatic gastroenteropancreatic neoplasms after multidisciplinary approach

Trifanescu Raluca , Iftimie Madalina , Mohora Alexandra , Toma Iustin , Trifanescu Oana , Poiana Catalina

Background: Prevalence of neuroendocrine neoplasms is increasing and multidisciplinary approach is mandatory. This study aimed to assess the outcome of patients with gastroenteropancreatic neoplasms (GEP NEN) presenting in a tertiary endocrine center.Methods: Retrospective study on 36 patients (16 M/20 F) with pathology confirmed GEP NEN, aged 51.9 ± 12.7 years. Serum chromogranin A, serotonin, neuron-specific enolase...

ea0032p326 | Clinical case reports - Thyroid / Others | ECE2013

Radiation-induced primary hypothyroidism in patients with head and neck cancer

Trifanescu Raluca , Ion Oana , Carsote Mara , Poiana Catalina

Background: Hypothyroidism is a frequent side effect of external radiotherapy of the cervical region for head and neck cancer. Up to 33% of irradiated patients developed primary hypothyroidism within 2 years after radiation therapy. The risk of hypothyroidism increases with radiation dose.Patients and methods: Four patients (2M/2F), aged 53.3±13.9 years, resident both in iodine sufficient (n=2) and iodine deficient areas (n=2), wer...

ea0016p235 | Diabetes and cardiovascular diseases | ECE2008

Cumulative incidence, timing and risk factors for thyroid dysfunction in 144 Romanian patients treated with amiodarone

Trifanescu Raluca-Alexandra , Fica Simona , Ion Oana-Gabriela , Coculescu Mihail

Aim: To assess cumulative incidence and risk factors for amiodarone-induced thyroid dysfunction (AITD) in a large cohort of Romanian subjects.Subjects and methods: One hundred and forty-four patients (59 M/85 F), mean age 61.4±0.9 years, treated 2.4±0.2 years with amiodarone were assessed for TSH, TT3, TT4 (immunoradiometric assays) and FT4, TPO Ab (microenzymatic immunoassays). Thirty-three patients were reside...

ea0063p1182 | Thyroid 3 | ECE2019

Cured medullary thyroid carcinoma after surgical treatment: does initial presentation matters?

Smarandoiu Georgiana Alexandra , Trifanescu Raluca , Popa Oana , Muresan Andrei , Gherghe Mirela , Poiana Catalina

Background: Surgery is the standard treatment in patients with medullary thyroid carcinoma (MTC), 43% being biochemically cured postoperative in a large series, the most important prognostic factor being the stage of the disease.Material and methods: We present 3 cases of biochemical cured patients after surgery with different preoperative presentation. Calcitonin and carcinoembryonic antigen (CEA) were measured by chemiluminescence. Histological examina...

ea0049ep1456 | Thyroid (non-cancer) | ECE2017

Anaplastic thyroid carcinoma and multinodular toxic goiter

Capraru Oana-Maria

A 69 years old female with cervical radiotherapy 25 years ago for an unknown condition, known with multinodular goitre and hyperthyroidism for 6 years, presented with a 6 months history of enlarged right supraclavicular mass, local pain with difficulty in mobilization of the right arm and weight loss. She also reported progressive bilateral exophtalmia especially on the right side, no dysphagia, hoarseness or dyspnoea. Thyroid hormone levels were normal on antithyroid drugs an...

ea0022p853 | Thyroid | ECE2010

Marked sensitivity of pituitary feedback to levothyroxine in asymptomatic primary autoimmune hypothyroidism

Trifanescu Raluca-Alexandra , Coculescu Mihail

Background: Few cases of hypersensitivity of thyroid–pituitary feedback in hypothyroid children were reported.Aim: To present a family with asymptomatic, severe biochemical primary autoimmune hypothyroidism who showed a marked sensitivity of pituitary feedback to levothyroxine treatment.Methods: TSH was measured by 3rd generation immunoassay kit.Case report: R.G, woman, aged 22, presented for asymptomati...

ea0056p90 | Clinical case reports - Pituitary/Adrenal | ECE2018

Opioid-induced secondary adrenal insufficiency

Petre Oana Alexandra , Albu Alice

Introduction: Opioids are commonly used for the treatment of pain, and their effects on the HPA (hypothalamic pituitary adrenal) axis may be under-recognised. In the present, a few non-systematic studies have investigated the effects of opioids on the HPA axis, but results have been conflicting. To our knowledge, there is only another case report of secondary adrenal insufficiency due to tramadol therapy, resulted in suppression on the HPA axis. We present the case of a 79 yea...

ea0037ep289 | Calcium and Vitamin D metabolism | ECE2015

Glucocorticoid induced osteoporosis: can we do more to prevent it?

Cristina Plaisanu , Vasilia Iorgoveanu , Raluca Trifanescu

Introduction: Osteoporosis is a well-known and extremely debated side effect of glucocorticoid therapy being able to generate vertebral fractures even at low doses. Our study highlights the need for better prevention through improved doctor-patient communication and correct implementation of available screening tools.Methods: Since August–December 2014 we distributed to 85 rheumatic patients a self-compiled questionnaire. We recorded patient data an...

ea0020p88 | Thyroid | ECE2009

What is the outcome of combined therapies in amiodarone-induced thyrotoxicosis?

Trifanescu Raluca-Alexandra , Ursu Horea , Purice Mariana

Objective: To assess the outcome of medical and ablative therapies in amiodarone-induced thyrotoxicosis (AIT).Subjects and methods: Seventy patients (32 M/38 F, aged 59.7±1.4 years) with AIT (24-type 1, 20-type 2 and 26-mixed forms) were followed-up 13.4±2.3 months. TSH was measured by immunoradiometric assay, TT3 and TT4 by chemiluminescence.Results: Antithyroid drugs (ATD) were used as single thera...